U of M researchers develop new online tool in fight against spread of HIV

December 18, 2007

A new Web-based software program is the latest tool University of Minnesota researchers are using to help fight the spread of HIV. A multidisciplinary team of researchers led by Joseph Konstan, a professor in computer science and engineering, and B. R. Simon Rosser, a professor in the School of Public Health, are embarking on a clinical trial this month to test a software program that aims to reduce risk-taking behavior associated with the spread of HIV and other sexually transmitted infections.

Konstan and Rosser's research team have been working for more than five years to create computer programs that assess risks undertaken by men seeking sex with other men through online venues. The team is now testing an online intervention program designed to reduce sexual risk-taking and the spread of sexually transmitted infections.

The software program asks users questions about issues such as body image, self esteem, sexual health and risk-taking behaviors. The program then offers information about HIV/AIDS related stories. "The goal of this research is to create a genuine online experience that promotes healthier sexual behavior and encourages people to take fewer risks in sexual encounters outside of cyberspace," Konstan said.

The research team's work has become a multi-phased, interdisciplinary project, called the Men's Internet Study (MINTS). The group is also partnering with a technology company -- Allen Interactions -- to develop the intervention techniques. Konstan and Rosser hope these trials will show that the Web-based program is effective in the prevention of risk-related behavior leading to sexually transmitted infections.

Rosser, director of the HIV/STI Intervention and Prevention Studies Program and the study's principal investigator, said his work with Konstan formed out of a discussion on ways to stop the spread of HIV/AIDS using computer technology. In addition to research, their partnership has evolved into a teaching collaboration. The professors began teaching a new e-public health course at the university this fall, drawing students from the School of Public Health, the Medical School, the Institute of Technology and the College of Liberal Arts.

Rosser said it is crucial to use the Internet for disease prevention, because their research shows that seeking sex is the most popular use for the Internet among high risk populations, such as men who have sex with men. "If we don't do [HIV prevention outreach] right or in a way that's most responsive, we're going to have a new HIV epidemic. There's enormous urgency in addressing gaps in HIV prevention," he added.

In addition to hopes for HIV prevention, MINTS researchers also hope their online prevention model can be used for other public health purposes. "The importance of the MINTS Internet study is not just addressing HIV," Rosser said, noting that the online prevention model could be adapted for things like cancer prevention, substance abuse interventions, and obesity prevention.
-end-
For more information about the MINTS study, visit http://new.epi.umn.edu/research/hips/mints.shtm.

University of Minnesota

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.